Moderna said it will ask the U.S. FDA and other regulators to authorize its COVID-19 vaccine in children younger than six years old based on data showing it generated a similar immune response to adults in its clinical trial.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook